News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Artimplant Year-End Report January – December 2007
February 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant (STO:ARTIB): * Net revenue for the fourth quarter increased to SEK 5.0 million (1.6) and for the year to SEK 16.3 million (5.5)*
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Business
New York City’s Life Sciences Scene Grows in Stature
September 11, 2025
·
5 min read
·
Angela Gabriel
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
September 11, 2025
·
1 min read
·
Tristan Manalac
Funding
Odyssey Rebounds Off Failed IPO With $213M Series D
September 10, 2025
·
1 min read
·
Dan Samorodnitsky
Layoffs
Lundbeck Offloads Assets to Three Partners as it Exits 27 Markets, Leaving 602 Jobless
September 10, 2025
·
1 min read
·
Tristan Manalac
